Extracorporeal membrane oxygenation in Pneumocystis jirovecii pneumonia: outcome in HIV and non-HIV patients
- PMID: 31727133
- PMCID: PMC6854795
- DOI: 10.1186/s13054-019-2661-9
Extracorporeal membrane oxygenation in Pneumocystis jirovecii pneumonia: outcome in HIV and non-HIV patients
Keywords: Acute respiratory distress syndrome; Extracorporeal membrane oxygenation; Outcome; Pneumocystis jirovecii.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Comment in
- 
  
  "Better be awake"-a role for awake extracorporeal membrane oxygenation in acute respiratory distress syndrome due to Pneumocystis pneumonia.Crit Care. 2019 Dec 23;23(1):418. doi: 10.1186/s13054-019-2703-3. Crit Care. 2019. PMID: 31870400 Free PMC article. No abstract available.
References
- 
    - Salzer HJF, Schafer G, Hoenigl M, Gunther G, Hoffmann C, Kalsdorf B, Alanio A, Lange C. Clinical, diagnostic, and treatment disparities between HIV-infected and non-HIV-infected immunocompromised patients with Pneumocystis jirovecii pneumonia. Respiration. 2018;96:52–65. doi: 10.1159/000487713. - DOI - PubMed
 
- 
    - Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009;374:1351–1363. doi: 10.1016/S0140-6736(09)61069-2. - DOI - PubMed
 
MeSH terms
LinkOut - more resources
- Full Text Sources
 
         
              